The potential reach of IV therapy has increased exponentially with the launch of NADclinic’s at-home kit called NADSQ.

“We're not just following the curve of scientific progress – we're setting it,” says company founder Iain de Havilland.

"With NADSQ, we’re making NAD+ therapy more accessible, empowering individuals to take control of their health and wellness no matter where they happen to be. This launch is a testament to our dedication to providing cutting-edge, effective wellness solutions."

The company specialises in infusions of nicotinamide adenine dinucleotide (NAD+), the molecule that supports biological processes such as ageing and immunity. NADclinic claims that maintaining levels of the molecule can help support skin and hair health, improve performance (mental and physical), boost longevity, encourage better sleep quality and assist with weight loss.

IV therapy is typically administered in settings overseen by doctors in spas, social wellness clubs and longevity centres globally. The services are growing increasingly popular and NADclinic already has a presence in 40 countries.

But with the arrival of NADSQ, products can now be up-sold for at-home use. The kit includes a syringe and NAD+ solution – enough for 20 x subcutaneous shots of 50mg or 100mg.

The process involves injecting NAD+ into the layer of fat just beneath the skin, typically in the stomach area. The brand has created detailed instructions for safe and effective self-administration.

The team plans to launch an Ozempic-style EpiPen applicator in the near future, offering an alternative method of administration.